Lipid-based NPs can also be utilized to reduce the secretion of certain immunosuppressive cytokines from tumor cells, such as vascular endothelial growth factor (VEGF), TGF-β and IL-10 [231]. The gene discussed is TGFB1; the disease is neoplasm.